mostraligabue
» » Endothelial Cell Function in Diabetic Microangiopathy: Problems in Methodology and Clinical Aspects: Satellite Symposium, Melbourne, November 1988 (Frontiers in Diabetes, Vol. 9)

ePub Endothelial Cell Function in Diabetic Microangiopathy: Problems in Methodology and Clinical Aspects: Satellite Symposium, Melbourne, November 1988 (Frontiers in Diabetes, Vol. 9) download

by G.M. Molinatti,R.S. Bar,F. Belfiore,M. Porta,F.M. Matschinsky

ePub Endothelial Cell Function in Diabetic Microangiopathy: Problems in Methodology and Clinical Aspects: Satellite Symposium, Melbourne, November 1988 (Frontiers in Diabetes, Vol. 9) download
Author:
G.M. Molinatti,R.S. Bar,F. Belfiore,M. Porta,F.M. Matschinsky
ISBN13:
978-3805550529
ISBN:
3805550529
Language:
Publisher:
S. Karger; 1 edition (February 21, 1990)
Category:
Subcategory:
Medicine
ePub file:
1676 kb
Fb2 file:
1658 kb
Other formats:
txt rtf azw lrf
Rating:
4.2
Votes:
476

Diabetes, Diabetic angiopathies, Health/Fitness.

Diabetes, Diabetic angiopathies, Health/Fitness.

In: Molinatti GM, Bar RS, Belfiore F, Porta M (eds) Endothelial cell function in diabetic microangiopathy: problems in methodology and clinical aspects. Karger, Basel, pp 86–96, 1990Google Scholar. 94. Stout RW, Glucose inhibits replication of cultured human endothelial cells. Diabetologia 23:436–439, 1982Google Scholar. 95. Lorenzi M, Cagliero E, Toledo S, Glucose toxicity for human endothelial cells in culture: delayed replication, disturbed cell cycle, and accelerated death. Diabetes 34:621–627, 1985Google Scholar.

Start by marking Endothelial Cell Function in Diabetic Microangiopathy .

Start by marking Endothelial Cell Function in Diabetic Microangiopathy: Problems in Methodology and Clinical Aspects (Frontiers in Diabetes) as Want to Read: Want to Read savin. ant to Read. Details (if other): Cancel. Thanks for telling us about the problem.

Bar, F. Belfiore, . orta, p. 8-42. Cite this publication. Jørgen Frøkjær-Jensen. All content in this area was uploaded by Jørgen Frøkjær-Jensen on Oct 15, 2016. Download full-text PDF.

Endothelial Cell Function in Diabetic Microangiopathy: Problems in Methodology and Clinical Aspects more. by Francesco Belfiore. This volume (212 pages), which documents the proceedings of an international symposium (Melbourne, Australia, 1988), is among the first to present a comprehensive overview of existing data in the field, an illuminating exchange of the ideas and opinions of major experts, and an authoritative analysis and evaluation of current methods for studying endothelial function.

cle{CF, title {Endothelial cell function in diabetic microangiopathy}, author {Massimo Porta and Marcelo La Selva and Pia Anna Molinatti and Gian Michele Molinatti}, journal {Diabetologia}, year {1987}, volume {30}, pages {601-609} }. Massimo Porta. Massimo Porta, Marcelo La Selva, +1 author Gian Michele Molinatti. Published in Diabetologia 1987.

Enzyme Regulation and Metabolic Diseases.

Its plasma levels are increased in diabetic microangiopathy but are not influenced by circulating glucose, insulin, or growth hormone, nor do they acutely affect platelet function in diabetes.

Diabetic coma is a medical emergency in which a person with diabetes mellitus is comatose (unconscious) because of. .Lung restriction in diabetes could result from chronic low-grade tissue inflammation, microangiopathy, and/or accumulation of advanced glycation end products

Diabetic coma is a medical emergency in which a person with diabetes mellitus is comatose (unconscious) because of one of the acute complications of diabetes: Severe diabetic hypoglycemia. Lung restriction in diabetes could result from chronic low-grade tissue inflammation, microangiopathy, and/or accumulation of advanced glycation end products

Any such proof would be of great clinical importance as the global . The changing epidemiology of diabetic microangiopathy in type 1 diabetes. Diabetologia 2005;48:1439–1444pmid:15986235.

Any such proof would be of great clinical importance as the global prevalence of diabetes is continuously on the rise, resulting in a high load of diabetic retinopathy and nephropathy in a large proportion of patients suffering from type 1 and type 2 diabetes (11,12). Comparison of molecular and functional dysregulation in diabetic retinopathy (11,15), cell death (19), and C-peptide action (10). OpenUrl CrossRef PubMed Web of Science.